Ascendis Pharma(MX:ASND1N)
MX$4,165.550.00 (0.00%)
MX:ASND1N
Ascendis Pharma earnings date
MX$4,165.55
At close:0.00 (0.00%)
Ascendis Pharma (ASND1N) Q3 2025 Earnings Report
0 Followers
MX:ASND1N Q3 2025 EPS Results
- Actual EPS
- -MXN 20.56
- Consensus EPS
- -MXN 5.02
- Beat/Miss
- Missed by -MXN 15.54
- One Year Ago EPS
- -MXN 35.36
MX:ASND1N Q3 2025 Revenue Results
- Actual Revenue
- MXN 4.64B
- Expected Revenue
- MXN 4.38B
- Beat/Miss
- Beat by +MXN 257.61M
- YoY Revenue Growth
- +292.96%
Earnings Announcement Details
- Quarter
- Q3 2025
- Date
- 11/12/2025
- Time
- After Close
- Conference Call
- Wednesday, November 12, 2025
MX:ASND1N Upcoming Earnings
Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.
Q3 2025 Earnings Call Audio
MX:ASND1N Q3 2025 Earnings Call
0:00 / 0:00
Q3 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ASND1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 17, 2027 | 2026 (Q4) | 31.62- | -11.31 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | 16.2222.20 | -20.56 | 208.00% (+42.76) | |
| Aug 13, 2026 | 2026 (Q2) | 30.7758.17 | -16.86 | 445.12% (+75.03) | |
| May 07, 2026 | 2026 (Q1) | ―200.42 | -32.48 | 717.09% (+232.90) | |
| Feb 11, 2026 | 2025 (Q4) | -1.64-11.31 | -13.16 | 14.06% (+1.85) | |
| Nov 12, 2025 | 2025 (Q3) | -5.02-20.56 | -35.36 | 41.86% (+14.80) | |
| Aug 07, 2025 | 2025 (Q2) | -26.44-16.86 | -39.26 | 57.07% (+22.41) | |
| May 01, 2025 | 2025 (Q1) | -30.16-32.48 | -47.28 | 31.30% (+14.80) | |
| Feb 12, 2025 | 2024 (Q4) | -20.23-13.16 | -31.66 | 58.44% (+18.50) | |
| Nov 14, 2024 | 2024 (Q3) | -32.17-35.36 | -55.3 | 36.06% (+19.94) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
